Syndax Pharmaceuticals(SNDX)
$9.20+0.07 (+0.77%)
SNDX
Syndax Pharmaceuticals earnings date
$9.20
At close:+0.07 (+0.77%)
Want to see SNDX full AI Analyst Report?
Syndax Pharmaceuticals (SNDX) Q2 2023 Earnings Report
1,063 Followers
SNDX Q2 2023 EPS Results
- Actual EPS
- -$0.64
- Consensus EPS
- -$0.72
- Beat/Miss
- Beat by +$0.08
- One Year Ago EPS
- -$0.62
SNDX Q2 2023 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/03/2023
- Time
- After Close
- Conference Call
- Thursday, August 3, 2023
SNDX Upcoming Earnings
Syndax Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
SNDX Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
SNDX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.53- | -0.78 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.50-0.55 | -0.7 | 21.43% (+0.15) | |
| Aug 04, 2026 | 2026 (Q2) | -0.45-0.55 | -0.83 | 33.73% (+0.28) | |
| Apr 30, 2026 | 2026 (Q1) | -0.61-0.48 | -0.98 | 51.02% (+0.50) | |
| Feb 26, 2026 | 2025 (Q4) | -0.58-0.78 | -1.1 | 29.09% (+0.32) | |
| Nov 03, 2025 | 2025 (Q3) | -0.72-0.70 | -0.98 | 28.57% (+0.28) | |
| Aug 04, 2025 | 2025 (Q2) | -1.02-0.83 | -0.8 | -3.75% (-0.03) | |
| May 05, 2025 | 2025 (Q1) | -1.25-0.98 | -0.85 | -15.29% (-0.13) | |
| Mar 03, 2025 | 2024 (Q4) | -0.84-1.10 | -1 | -10.00% (-0.10) | |
| Nov 05, 2024 | 2024 (Q3) | -1.07-0.98 | -0.73 | -34.25% (-0.25) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


